Literature DB >> 11840433

Management of uveitis: a rheumatologic perspective.

Justine R Smith1, James T Rosenbaum.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11840433     DOI： 10.1002/art.503

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  9 in total

1.  [A symptom oriented diagnostic approach to the workup of secondary forms of uveitis -- an internet based program for better and easier orientation in differential diagnosis].

Authors:  U Wiehler; R Schmidt; S Skonetzki; M Becker
Journal:  Ophthalmologe       Date:  2006-05       Impact factor: 1.059

Review 2.  In vivo imaging of the immune response in the eye.

Authors:  Doran B Spencer; Ellen J Lee; Tatsushi Kawaguchi; James T Rosenbaum
Journal:  Semin Immunopathol       Date:  2008-03-05       Impact factor: 9.623

Review 3.  Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility.

Authors:  Andrea Latini; Cinzia Ciccacci; Giuseppe Novelli; Paola Borgiani
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

4.  Characterization and outcome of uveitis in 350 patients with spondyloarthropathies.

Authors:  Percival D Sampaio-Barros; Roseneide A Conde; Rubens Bonfiglioli; Manoel B Bértolo; Adil M Samara
Journal:  Rheumatol Int       Date:  2006-09-07       Impact factor: 2.631

5.  A functional variant of pre-miRNA-196a2 confers risk for Behcet's disease but not for Vogt-Koyanagi-Harada syndrome or AAU in ankylosing spondylitis.

Authors:  Jian Qi; Shengping Hou; Qi Zhang; Dan Liao; Lin Wei; Jing Fang; Yan Zhou; Aize Kijlstra; Peizeng Yang
Journal:  Hum Genet       Date:  2013-08-09       Impact factor: 4.132

6.  Retrospective study on the effects of immunosuppressive therapy in uveitis associated with rheumatic diseases in Korea.

Authors:  Sang Yeob Lee; Won Tae Chung; Woo Jin Jung; Sung Won Lee
Journal:  Rheumatol Int       Date:  2011-12-24       Impact factor: 2.631

Review 7.  Gateway Reflex and Mechanotransduction.

Authors:  Shiina Matsuyama; Yuki Tanaka; Rie Hasebe; Shintaro Hojyo; Masaaki Murakami
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

8.  Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study.

Authors:  Ana Belen Rivas; Amanda Lopez-Picado; Valentina Calamia; Ester Carreño; Lidia Cocho; Miguel Cordero-Coma; Alex Fonollosa; Felix M Francisco Hernandez; Angel Garcia-Aparicio; Javier Garcia-Gonzalez; Jose Juan Mondejar; Leticia Lojo-Oliveira; Llucí Martínez-Costa; Santiago Munoz; Diana Peiteado; Jose Antonio Pinto; Beatriz Rodriguez-Lozano; Esperanza Pato; David Diaz-Valle; Elena Molina; Luis Alberto Tebar; Luis Rodriguez-Rodriguez
Journal:  BMJ Open       Date:  2022-03-22       Impact factor: 2.692

9.  A functional variant of PTPN22 confers risk for Vogt-Koyanagi-Harada syndrome but not for ankylosing spondylitis.

Authors:  Qi Zhang; Jian Qi; Shengping Hou; Liping Du; Hongsong Yu; Qingfeng Cao; Yan Zhou; Dan Liao; Aize Kijlstra; Peizeng Yang
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.